CBRE GROUP INC - A (CBRE) Fundamental Analysis & Valuation

NYSE:CBRE • US12504L1098

Current stock price

134.81 USD
+0.06 (+0.04%)
At close:
134.81 USD
0 (0%)
After Hours:

This CBRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CBRE Profitability Analysis

1.1 Basic Checks

  • In the past year CBRE was profitable.
  • CBRE had a positive operating cash flow in the past year.
  • CBRE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CBRE had a positive operating cash flow.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CBRE has a better Return On Assets (3.75%) than 85.71% of its industry peers.
  • CBRE has a Return On Equity of 13.03%. This is amongst the best in the industry. CBRE outperforms 93.65% of its industry peers.
  • CBRE has a better Return On Invested Capital (5.08%) than 74.60% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 5.74%.
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROIC 5.08%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.85%, CBRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • CBRE's Profit Margin has declined in the last couple of years.
  • CBRE's Operating Margin of 3.19% is in line compared to the rest of the industry. CBRE outperforms 57.14% of its industry peers.
  • CBRE's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CBRE (18.66%) is comparable to the rest of the industry.
  • CBRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CBRE Health Analysis

2.1 Basic Checks

  • CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CBRE has been reduced compared to 1 year ago.
  • The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CBRE has a worse debt to assets ratio.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • CBRE has an Altman-Z score of 3.03. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.03, CBRE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of CBRE is 6.56, which is on the high side as it means it would take CBRE, 6.56 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CBRE (6.56) is better than 68.25% of its industry peers.
  • A Debt/Equity ratio of 0.87 indicates that CBRE is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CBRE (0.87) is worse than 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Altman-Z 3.03
ROIC/WACC0.59
WACC8.59%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that CBRE should not have too much problems paying its short term obligations.
  • CBRE's Current ratio of 1.09 is on the low side compared to the rest of the industry. CBRE is outperformed by 71.43% of its industry peers.
  • CBRE has a Quick Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CBRE has a worse Quick ratio (1.09) than 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CBRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.05% over the past year.
  • Measured over the past years, CBRE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.27% on average per year.
  • CBRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.38%.
  • CBRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.22% yearly.
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%

3.2 Future

  • Based on estimates for the next years, CBRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.85% on average per year.
  • The Revenue is expected to grow by 9.11% on average over the next years. This is quite good.
EPS Next Y18.69%
EPS Next 2Y17.39%
EPS Next 3Y16.01%
EPS Next 5Y16.85%
Revenue Next Year11.85%
Revenue Next 2Y10.44%
Revenue Next 3Y9.9%
Revenue Next 5Y9.11%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. CBRE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.10, the valuation of CBRE can be described as rather expensive.
  • CBRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 74.60% of the companies in the same industry.
  • CBRE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 17.77, the valuation of CBRE can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CBRE indicates a rather cheap valuation: CBRE is cheaper than 84.13% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. CBRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.1
Fwd PE 17.77
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 69.84% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 68.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 33.35
EV/EBITDA 19.48
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • CBRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CBRE has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CBRE's earnings are expected to grow with 16.01% in the coming years.
PEG (NY)1.13
PEG (5Y)1.48
EPS Next 2Y17.39%
EPS Next 3Y16.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBRE Dividend Analysis

5.1 Amount

  • No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE Fundamentals: All Metrics, Ratios and Statistics

CBRE GROUP INC - A

NYSE:CBRE (3/26/2026, 8:08:21 PM)

After market: 134.81 0 (0%)

134.81

+0.06 (+0.04%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-12
Earnings (Next)04-22
Inst Owners99.07%
Inst Owner Change0.57%
Ins Owners0.63%
Ins Owner Change4.48%
Market Cap39.79B
Revenue(TTM)40.55B
Net Income(TTM)1.16B
Analysts83
Price Target189.93 (40.89%)
Short Float %1.35%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.04%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.74%
Min EPS beat(4)0.04%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)7.3%
EPS beat(16)15
Avg EPS beat(16)8.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)1.13%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)-1.28%
PT rev (3m)1.08%
EPS NQ rev (1m)4.23%
EPS NQ rev (3m)3.92%
EPS NY rev (1m)0.84%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)1.43%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)2.06%
Valuation
Industry RankSector Rank
PE 21.1
Fwd PE 17.77
P/S 0.98
P/FCF 33.35
P/OCF 25.52
P/B 4.48
P/tB N/A
EV/EBITDA 19.48
EPS(TTM)6.39
EY4.74%
EPS(NY)7.58
Fwd EY5.63%
FCF(TTM)4.04
FCFY3%
OCF(TTM)5.28
OCFY3.92%
SpS137.39
BVpS30.08
TBVpS-3.88
PEG (NY)1.13
PEG (5Y)1.48
Graham Number65.76
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROCE 6.97%
ROIC 5.08%
ROICexc 5.57%
ROICexgc 11.69%
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
FCFM 2.94%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
ROICexc(3y)6.87%
ROICexc(5y)8.07%
ROICexgc(3y)14.53%
ROICexgc(5y)18.56%
ROCE(3y)8.23%
ROCE(5y)9.39%
ROICexgc growth 3Y-21.33%
ROICexgc growth 5Y-6.1%
ROICexc growth 3Y-16.05%
ROICexc growth 5Y-7%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Debt/EBITDA 3.46
Cap/Depr 39.44%
Cap/Sales 0.9%
Interest Coverage 2.89
Cash Conversion 70.19%
Profit Quality 103.11%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 3.03
F-Score5
WACC8.59%
ROIC/WACC0.59
Cap/Depr(3y)44.67%
Cap/Depr(5y)43.27%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.86%
Profit Quality(3y)88.53%
Profit Quality(5y)96.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
EPS Next Y18.69%
EPS Next 2Y17.39%
EPS Next 3Y16.01%
EPS Next 5Y16.85%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%
Revenue Next Year11.85%
Revenue Next 2Y10.44%
Revenue Next 3Y9.9%
Revenue Next 5Y9.11%
EBIT growth 1Y-15.16%
EBIT growth 3Y-0.84%
EBIT growth 5Y5.11%
EBIT Next Year51.3%
EBIT Next 3Y23.17%
EBIT Next 5Y16.26%
FCF growth 1Y-14.85%
FCF growth 3Y-4.48%
FCF growth 5Y-5.27%
OCF growth 1Y-8.72%
OCF growth 3Y-1.46%
OCF growth 5Y-3.16%

CBRE GROUP INC - A / CBRE Fundamental Analysis FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status of CBRE GROUP INC - A (CBRE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


What is the profitability of CBRE stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for CBRE stock?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 18.69% in the next year.